Market participants widely expect 2025 to be a boom year for IPOs as President-elect Donald Trump eases regulation while the ...
The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...
In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
The biotech has applied to list on the Nasdaq under the ticker “MTSR.” Metsera plans to use the IPO to fund a phase 3 trial of MET-097i—a subcutaneous GLP-1 receptor agonist that is the ...